Rhythm Pharmaceuticals, Inc. (RYTM)
105.24
-0.18
(-0.17%)
USD |
NASDAQ |
Sep 03, 10:04
Rhythm Pharmaceuticals Cash from Operations (TTM) : -105.35M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -105.35M |
| March 31, 2026 | -119.51M |
| December 31, 2025 | -115.68M |
| September 30, 2025 | -109.13M |
| June 30, 2025 | -107.72M |
| March 31, 2025 | -113.49M |
| December 31, 2024 | -113.88M |
| September 30, 2024 | -124.42M |
| June 30, 2024 | -128.45M |
| March 31, 2024 | -140.47M |
| December 31, 2023 | -136.16M |
| September 30, 2023 | -140.77M |
| June 30, 2023 | -158.51M |
| March 31, 2023 | -156.23M |
| December 31, 2022 | -173.43M |
| September 30, 2022 | -179.90M |
| June 30, 2022 | -173.07M |
| March 31, 2022 | -166.10M |
| December 31, 2021 | -146.00M |
| September 30, 2021 | -134.65M |
| Date | Value |
|---|---|
| June 30, 2021 | -121.52M |
| March 31, 2021 | -119.41M |
| December 31, 2020 | -121.98M |
| September 30, 2020 | -125.08M |
| June 30, 2020 | -131.65M |
| March 31, 2020 | -127.47M |
| December 31, 2019 | -122.75M |
| September 30, 2019 | -111.51M |
| June 30, 2019 | -94.85M |
| March 31, 2019 | -81.78M |
| December 31, 2018 | -62.06M |
| September 30, 2018 | -48.96M |
| June 30, 2018 | -40.43M |
| March 31, 2018 | -34.10M |
| December 31, 2017 | -29.46M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | -20.48M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| BioMarin Pharmaceutical, Inc. | 857.09M |
| Cytokinetics, Inc. | -555.45M |
| Exelixis, Inc. | 1.183B |